WILMINGTON, Del., Nov. 22 /PRNewswire-FirstCall/ -- AstraZeneca is proud to support the National Council on the Aging (NCOA) and the Access to Benefits Coalition (ABC) in launching My Medicare Matters, a comprehensive, community-based initiative that will help patients and their families across the country learn about the Medicare Prescription Drug Benefit. We commend these organizations, as well as their many national, regional and community member organizations, for bringing this important program to our communities.
The Medicare Modernization Act is the single biggest change in health care delivered by the U.S. government in nearly forty years and its impact will be felt by millions of Americans throughout the country. This is why we are doing our part at this historic moment to support education and outreach efforts, like My Medicare Matters, that will reach people at the local level with real-time counseling and information. In addition to in-kind resources, AstraZeneca is providing an initial grant of $10 million to the NCOA in order to launch this groundbreaking initiative.
This benefit is going to be vital in the lives of millions of people with Medicare, and it is very important that they have a good understanding of the prescription program and how it will help them. If ever there was a logical time for a public-private partnership in support of educational outreach, it is now. And AstraZeneca encourages other companies and organizations to become involved in this much-needed outreach and to support groups like the NCOA and ABC.
At AstraZeneca, people’s health is at the center of what we do, and we face the challenge of improving your health, your family’s health and the health of your community, each and every day. Our goal is not only to develop medicines that improve lives and patient health, but also address issues relating to patients’ ability to access these medicines. Today’s announcement reinforces our commitment to that goal.
AstraZeneca
CONTACT: Carla Burigatto, AstraZeneca, +1-302-886-5953,Carla.burigatto@astrazeneca.com, or Andy Izquierdo, AstraZeneca,+1-202-350-5530, andy.izquierdo@astrazeneca.com
Web site: http://www.astrazeneca-us.com/
Company News On-Call: http://www.prnewswire.com/comp/985887.html/
